Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details Narrative)

v3.8.0.1
NON CONTROLLING INTEREST (Details Narrative) - USD ($)
1 Months Ended
Jul. 28, 2016
Mar. 31, 2018
Dec. 31, 2017
BioCorRx Pharmaceuticals, Inc [Member]      
Licensing rights, carrying value   $ 250,000 $ 250,000
Officers Member      
Ownership 24.20%    
Retained ownership 75.80%